Bill too frequently and CMS gives denials and physicians find it impossible to know the right time, says Sallie Gustafson, RN, director of medical affairs at Murj.
The FDA has approved inebilizumab-cdon (Uplizna, Amgen) for adults with anti-acetylcholine receptor and anti-muscle specific tyrosine kinase antibody positive generalized myasthenia gravis, according ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback